BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26138778)

  • 21. Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair.
    Sonoda E; Zhao GY; Kohzaki M; Dhar PK; Kikuchi K; Redon C; Pilch DR; Bonner WM; Nakano A; Watanabe M; Nakayama T; Takeda S; Takami Y
    DNA Repair (Amst); 2007 Mar; 6(3):280-92. PubMed ID: 17123873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
    Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
    Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation.
    Sak A; Grehl S; Engelhard M; Wierlemann A; Kaelberlah HP; Erichsen P; Pöttgen C; Groneberg M; Stuschke M
    Clin Cancer Res; 2009 Apr; 15(8):2927-34. PubMed ID: 19336520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells].
    Yang Z; Sun C; Liu Y; Gong C; Chen G; Weng D
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):805-10. PubMed ID: 25620475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.
    Tan KB; Mattern MR; Boyce RA; Schein PS
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7668-71. PubMed ID: 2823270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.
    Zhen W; Link CJ; O'Connor PM; Reed E; Parker R; Howell SB; Bohr VA
    Mol Cell Biol; 1992 Sep; 12(9):3689-98. PubMed ID: 1380646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.
    Wagner W; Ciszewski WM; Kania KD
    Cell Commun Signal; 2015 Jul; 13():36. PubMed ID: 26208712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
    Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
    Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
    Deng Y; Guo W; Xu N; Li F; Li J
    Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
    Ko JC; Ciou SC; Cheng CM; Wang LH; Hong JH; Jheng MY; Ling ST; Lin YW
    Carcinogenesis; 2008 Jul; 29(7):1448-58. PubMed ID: 18544565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Characterization of Cisplatin Response Uncovers Priming of Cisplatin-Induced Genes in a Resistant Cell Line.
    Golan Berman H; Chauhan P; Shalev S; Hassanain H; Parnas A; Adar S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard.
    Fan S; Chang JK; Smith ML; Duba D; Fornace AJ; O'Connor PM
    Oncogene; 1997 May; 14(18):2127-36. PubMed ID: 9174048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-irradiated quiescent cells repair directly induced double-strand breaks but accumulate persistent double-strand breaks during subsequent DNA replication.
    Minakawa Y; Atsumi Y; Shinohara A; Murakami Y; Yoshioka K
    Genes Cells; 2016 Jul; 21(7):789-97. PubMed ID: 27251002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination.
    Zhao Q; Guan J; Qin Y; Ren P; Zhang Z; Lv J; Sun S; Zhang C; Mao W
    Biomed Pharmacother; 2018 Jan; 97():115-119. PubMed ID: 29080451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair after irradiation in glioma cells and normal human astrocytes.
    Short SC; Martindale C; Bourne S; Brand G; Woodcock M; Johnston P
    Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.